Basilea had previously guided for an operating loss for 2022 of CHF 10 million to 15 million. Adesh Kaul, Chief Financial Officer, commented: “Our strong 2022 financial performance is the result of …
Read Full Story at source (may require registration)
Latest posts by CHF Editor (see all)
- Roche: Lower Guidance In 2023, But Positive Trajectory - February 2, 2023
- Roche’s (RHHBY) 2022 Core Earnings Grow, 2023 Outlook Dismal - February 2, 2023
- What to know about congestive heart failure and coughing - February 2, 2023